INVESTIGACIÓN EN ONCOLOGÍA DE CABEZA Y CUELLO
IOCC
Centro de Investigación Biomédica en Red de Cáncer
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Cáncer (36)
2024
-
A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma
eBioMedicine, Vol. 102
-
Combined PIK3CA and SOX2 Gene Amplification Predicts Laryngeal Cancer Risk beyond Histopathological Grading
International Journal of Molecular Sciences, Vol. 25, Núm. 5
-
Hippo-YAP signaling activation and cross-talk with PI3K in oral cancer: A retrospective cohort study
Oral Diseases, Vol. 30, Núm. 2, pp. 149-162
-
Lectin-like Transcript-1 (LLT1) Expression in Oral Squamous Cell Carcinomas: Prognostic Significance and Relationship with the Tumor Immune Microenvironment
International journal of molecular sciences, Vol. 25, Núm. 8
-
Low-Level Expression of p-S6 Is Associated with Nodal Metastasis in Patients with Head and Neck Cutaneous Squamous Cell Carcinoma
International Journal of Molecular Sciences, Vol. 25, Núm. 8
-
Prognostic value of preoperative inflammatory ratios in early glottic cancer treated with transoral laser surgery
Head and Neck, Vol. 46, Núm. 4, pp. 819-830
-
Results of salvage neck dissection after chemoradiation in locally advanced head and neck squamous cell carcinoma
European Archives of Oto-Rhino-Laryngology, Vol. 281, Núm. 2, pp. 945-951
-
VAV2 orchestrates the interplay between regenerative proliferation and ribogenesis in both keratinocytes and oral squamous cell carcinoma
Scientific Reports, Vol. 14, Núm. 1
2023
-
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma
Nature Communications, Vol. 14, Núm. 1
-
Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling
Biomedicine and Pharmacotherapy, Vol. 162
-
Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy
Molecular Cancer, Vol. 22, Núm. 1
-
Chemo-Immunotherapy: A New Trend in Cancer Treatment
Cancers, Vol. 15, Núm. 11
-
Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcoma
Redox Biology, Vol. 62
-
Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cells
Free Radical Biology and Medicine, Vol. 209, pp. 127-134
-
Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders
International Journal of Molecular Sciences, Vol. 24, Núm. 18
-
Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer
Biomedicines, Vol. 11, Núm. 1
-
Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review †
Cancers, Vol. 15, Núm. 3
-
Neutrophil to Lymphocyte Ratio in Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis †
Cancers, Vol. 15, Núm. 3
-
Prognostic Significance of β-Catenin in Relation to the Tumor Immune Microenvironment in Oral Cancer
Biomedicines, Vol. 11, Núm. 10
-
Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis †
Biomedicines, Vol. 11, Núm. 8